NCT00799682

Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®

An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Ophthalmic Consultants of Long Island · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine if there is a difference in the ocular signs and symptoms of subjects' eyes using Xalatan® 0.005% versus Travatan Z® 0.004% based on the outcome of subject assessment and clinical assessment in patients with Ocular Hypertension or Glaucoma with mild to moderate dry eye at baseline in accordance with the Oxford Grading Scale.

Conditions

• Dry Eye Disease

Interventions

Type	Name	Description
DRUG	Xalatan	0.005% 1 drop in each eye daily between 7:00 p.m. and 9:00 p.m.
DRUG	Travatan Z	0.004%, 1 drop in each eye daily between 7:00 p.m. and 9:00 p.m.

Timeline

• Start date: 2008-10-01
• Primary completion: 2011-01-01
• Completion: 2011-02-01
• First posted: 2008-12-01
• Last updated: 2011-07-21

Locations

5 sites across 1 country: United States